The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; Merck Serono
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; PharmaMar; Roche
Research Funding - Boehringer Ingelheim; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; PharmaMar
LUX-head and neck 2: Randomized, double-blind, placebo-controlled, phase III trial of afatinib as adjuvant therapy after chemoradiation (CRT) in primary unresected, high/intermediate-risk, squamous cell cancer of the head and neck (HNSCC) patients (pts).
 
Barbara Burtness
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Debiopharm Group; MedImmune; Merck; VentiRx
Research Funding - Merck
 
Robert I. Haddad
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Merck; Pfizer
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst); VentiRx (Inst)
 
José Dinis
No Relationships to Disclose
 
Jose Manuel Trigo Perez
No Relationships to Disclose
 
Tomoya Yokota
No Relationships to Disclose
 
Luciano De Souza Viana
Research Funding - Boehringer Ingelheim (Inst)
 
Ilya Romanov
Honoraria - Bayer; Eisai
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Bayer; Eisai; Merck
Research Funding - Boehringer Ingelheim
Travel, Accommodations, Expenses - Eisai
 
Jan Baptist Vermorken
Honoraria - Amgen; Innate Pharma; Merck; PCI Biotech; Synthon
Consulting or Advisory Role - Amgen; Innate Pharma; Merck; PCI Biotech; Synthon
Speakers' Bureau - Merck; Sanofi
 
Jean Bourhis
Consulting or Advisory Role - Merck
 
Makoto Tahara
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Merck Serono; Takeda
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Ono Pharmaceutical; Pfizer
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Merck Sharp & Dohme (Inst); NanoCarrier (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst)
 
J.G.M. Segalla
No Relationships to Disclose
 
Amanda Psyrri
Honoraria - Merck Serono
Consulting or Advisory Role - AstraZeneca; Merck Serono; MSD Oncology; Pfizer
Other Relationship - Bristol-Myers Squibb; Janssen Oncology
 
Irina Vasilevskaya
No Relationships to Disclose
 
Chaitali Singh Nangia
Speakers' Bureau - Merck
 
Manuel Chaves-Conde
Travel, Accommodations, Expenses - Merck
 
Bushi Wang
Employment - Boehringer Ingelheim
 
Neil Gibson
Employment - Boehringer Ingelheim
 
Eva Ehrnrooth
Employment - Boehringer Ingelheim
 
Kevin Harrington
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; MSD
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; MSD
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); MSD (Inst); Pfizer (Inst)
 
Ezra E.W. Cohen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Human Longevity, Inc; Merck; Pfizer
Speakers' Bureau - Bayer; Eisai